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Summary
 Background: Defects in the enzyme coproporphyrinogen oxidase result in accumulation of porphyrins which 
may affect the severity of a subset of porphyrias. Thus evaluation of this enzyme for substrate se-
lectivity is of value. Kinetic evaluations of recombinant human coproporphyrinogen oxidase have 
been undertaken using six di- and tripropionate analogs of the natural substrate coproporphyrin-
ogen-III. These substrate analogs were modiﬁ ed by having alkyl groups in place of one or both of 
the ring 13- or 17-propionate moieties.
 Material/Methods: Cloned human enzyme was incubated with analogs under apparent ﬁ rst order conditions and with 
various substrate concentrations. The kinetic values, Km and Vmax, were determined.
 Results: Relative to the authentic substrate, the Km values for the 13-ethyl, dimethyl and diethyl porphy-
rinogens were very comparable whereas the Km values were much higher using dipropyl and dibu-
tyl porphyrinogen and much lower for the 17-ethyl analog. For the dipropionate analogs, the Vmax 
values were an apparent function of the carbon length of the substituent on the C and D rings, 
with longer carbon length severely reducing product formation by some 4–5 orders of magnitude. 
Also, the two isomeric tripropionates that were tested indicated that it was more detrimental to 
have an ethyl group at the 13-position for both binding and catalysis.
 Conclusions: This work extends our understanding of porphyrin ring substituent effects reported by Cooper 
et al. (2005). The substituents on both the C and D rings have signiﬁ cant effects on both the sub-
strate binding and catalysis by this important enzyme.
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BACKGROUND
The enzyme coproporphyrinogen oxidase (copro’gen ox-
idase, EC 1.3.3.3) is the sixth enzyme in the biosynthetic 
pathway for the production of heme [1]. Heme, when cou-
pled to a globular protein, is the principal molecular oxy-
gen carrier through out the body [1]. Malfunctions in the 
gene encoding copro’gen oxidase as well as other enzymes 
in this pathway, such as delta-aminolevulinic acid synthase, 
can cause a build up of porphyrins and ultimately lead to 
a category of diseases called porphyrias [2]. The authen-
tic substrate for copro’gen oxidase is coproporphyrinogen-
III (copro’gen-III) which undergoes two sequential oxida-
tive decarboxylations to yield the protoporphyrinogen-IX 
(proto’gen-IX) product. The overall reaction catalyzed by 
copro’gen oxidase is shown in Figure 1. The mechanism by 
which copro’gen oxidase carries out the sequential oxida-
tive decarboxylations is as yet unknown, although some stud-
ies on ring substituent effects on substrate selectivity have 
been reported (reviewed by Jones and Lash [3]). A model, 
Figure 2, of substrate binding was developed from the data 
obtained using substrate analogs [4]. This particular model 
indicates that there are a minimum of two binding sites, X 
and Z, as well as a catalytic site, Y. The model proposes that 
oxidative decarboxylations occur at the catalytic site and 
the substrate position is stabilized by the X and Z sites. The 
Z site can only accommodate a relatively small alkyl group 
such as a vinyl, methyl or hydrogen. The X site requires a 
charged group such as a propionate, and it was postulated 
that the substituent interacts with a positively charged ami-
no acid. Recently, using site directed mutagenesis, arginine 
262 and 401 were reported to be involved in substrate bind-
ing [5]. These binding requirements favor the sequence of 
peripheral substituents R Me P Me P (R=methyl, vinyl, or H, 
Me=methyl, P=propionate) for catalysis [4]. After the ﬁ rst 
oxidative decarboxylation on the A ring of copro’gen-III, 
the authentic monovinyl intermediate harderoporphyrin-
ogen (hardero’gen) is generated. The model purposed by 
Lash et al. [4] suggests that a 90° clockwise turn is required 
to put the B ring of hardero’gen in the correct position for 
the second oxidative decarboxylation to generate the divi-
nyl product, proto’gen-IX. Although it has been reported 
that copro’gen oxidase is a homodimer, each monomer ap-
pears to have its own active site [6,7].
To better evaluate substrate recognition of the active site of 
human copro’gen oxidase the use of substrate analogs that 
differ at the C and D ring positions have been employed. 
The analogs were synthesized by replacing propionates on 
the C and/or D ring positions with methyl, ethyl, propyl, 
or butyl groups [4,8]. Thus substituent effects of carbon 
chain length and loss of the carboxylate group could be 
evaluated. The porphyrinogens that were tested are shown 
in Figure 3. Previous studies using these di- and tripropio-
nate substrates were done with a crude copro’gen oxidase 
preparation obtained from chicken red blood cells (CRBC) 
[4,8,9]. However, data evaluation was difﬁ cult since endog-
enous proto’gen-IX was present in these enzyme prepara-
tions. This endogenous product presented a challenge to 
quantitate the amount of newly formed product being pro-
duced from the enzyme assays. However, with the use of 
the recombinant human copro’gen oxidase, that particu-
lar challenge is eliminated. We now report the kinetic eval-
uation using highly puriﬁ ed recombinant enzyme using 
the di- and tripropionate analogs. The kinetic constants are 
compared with previous data obtained using the chicken 
red blood cell enzyme. Using recombinant enzyme, time 
course studies were performed with each analog to deter-
mine the apparent ﬁ rst order conditions to determine the 
Km and Vmax values reported here. Also kcat and kcat/Km val-
ues were calculated.
MATERIAL AND METHODS
Isolation and puriﬁ cation of human recombinant 
copro’gen oxidase
The human cloned his-tagged enzyme was expressed in 
Escherichia coli with the vector pET21d-CO containing the lac 
operon to better control enzyme production [5]. The E. coli 
were grown (overnight, 37°C, with shaking) in a liter of me-
dia consisting of 10 g tryptone (Fisher Chemical Company), 
5 g yeast extract (Sigma Chemical Company), 10 g NaCl, 50 
μg/ml ampicillin, and 34 μg/ml chloramphenicol (Sigma 
Chemical Company). To yield a higher concentration of 
protein, the cells were induced with 1 mM isopropyl-b-D-
thiogalactoside (IPTG) after the initial 24 hours of growth 
then allowed to grow for an additional 3 hours. Cells were 
centrifuged (10 min at 11,900 × g), and resuspended in 60 
ml of resuspension buffer containing 0.0105 g of phenyl-
methylsulfonylﬂ uoride (Sigma Chemical Company), 12.1 
g/L Trisma base, 6.9 g/L NaH2PO4, and 17.5 g/L NaCl, pH 
8 then lysed using a French® hydraulic pressure cell (Sim-
Aminco Spectronic Instruments) at 20,000 psi. The lysate 
was centrifuged for 30 min at 27,200 × g. The resulting su-
pernatant was applied to a nickel afﬁ nity column (Qiagen), 
and the his-tagged enzyme was eluted with resuspension buf-
fer containing 250 mM imidazole following the method of 
Medlock and Dailey [10]. The Bradford Protein Assay [11] 
using bovine serum albumin (BSA) as a standard was used 
to evaluate the concentration of the eluted protein.
Enzyme assay
Recombinant human copro’gen oxidase was assayed using 
the micro method of Jones et al. [12]. In a ﬁ nal reaction vol-
ume of 300 μL, puriﬁ ed enzyme (15 μg) was incubated with 
10 μL of the various freshly reduced substrate analogs (Figure 
3) to give a ﬁ nal concentration of 0.8 μM; the dipropionate 
analogs [mesoporphyrinogen-VI (meso’gen-VI, diethyl por-
phyrinogen), dimethyl, dipropyl, and dibutyl] and tripropi-
onate analogs [13-ethyl, 17-ethyl] were incubated at 0.5, 1, 2, 
5, 10, 30, 60, or 120 minutes to determine the initial velocity 
(V0). Zero time incubations were also done as substrate sta-
bility controls. Substrate concentration was also varied under 
initial velocity conditions for the kinetic analysis. Reactions 
were carried out at 37°C, stopped with 3/7 (v/v) ethyl ace-
tate/acetic acid, neutralized with 3% sodium acetate, extracted 
and Fischer esteriﬁ ed overnight. After esteriﬁ cation, porphy-
rins were neutralized, extracted, then separated using High 
Performance Liquid Chromatography (HPLC) (Beckman 
System Gold). A normal phase column (Beckman Silica 5 μ, 
4.6 mm × 25 cm) was used with a mobile phase of 20/80 (v/v) 
ethyl acetate/cyclohexane at a ﬂ ow rate of 1.3 ml/min; eluates 
were evaluated spectrophotometrically at 404 nm. Data were 
analyzed using the Gold Nouveau Software and reported as 
nmol product/min/pmol enzyme. Graphic analysis and cal-
culated values were obtained using SigmaPlot 2000.
Basic Research Med Sci Monit, 2008; 14(1): BR1-7
BR2
Electronic PDF security powered by ISL-science.com
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
Th
is
 c
op
y 
is
 fo
r 
ed
uc
at
io
na
l u
se
 o
nl
y 
- d
is
tr
ib
ut
io
n 
pr
oh
ib
it
ed
.  
   
ED
UC
AT
IO
NA
L 
US
E
RESULTS
Kinetic analysis
Shown in Figures 4–9 are the graphical representations of 
Vo (nmol product/min/pmol recombinant enzyme) as a 
function of substrate concentration (μM) for all the sub-
strate analogs tested. From these graphs Km, Vmax, kcat and 
kcat/Km were calculated (Table 1). Each dipropionate ana-
log used resulted in a formation of only monovinyl prod-
uct (Figure 3). Of the two tripropionates, only the 17-eth-
yl resulted in signiﬁ cant divinyl product formation whereas 
only the monovinyl product was generated as a major prod-
uct following incubation with the 13-ethyl porphyrinogen. 
With the 13-ethyl analog, however, a second oxidative de-
carboxylation resulting in a divinyl product was noted as a 
minor product at longer incubation times (greater than 30 
min; Figure 3). The apparent binding afﬁ nities (Km values) 
for different substrates varied from 0.011 to 11.0 μM with 
the 17-ethyl analog having the best afﬁ nity for the recom-
binant copro’gen oxidase, while the dipropyl and dibutyl 
analogs had the worst. Maximum velocities for each sub-
strate analog varied widely from 3.6×10–7 to 1.7×10–3 nmol 
product/min/pmol enzyme with the lowest value for the 
dibutyl analog and the highest value for the 13-ethyl ana-
log. The values for kcat, a measurement of catalytic turn-
over, exhibited a range of 3.6×10–4 to 1.7 min–1 with dibu-
tyl having the lowest value and 13-ethyl having the largest 
value. The catalytic efﬁ ciency, kcat/Km, values varied over a 
very wide range from 3.4×10–5 for the dibutyl analog to 9.1 
min–1 μM–1 for the 17-ethyl analog.
DISCUSSION
The human recombinant copro’gen oxidase recognized all 
of the substrate analogs studied but was only able to car-
ry out the ﬁ rst oxidative decarboxylation with the dipropi-
onate analogs. The tripropionate 17-ethyl porphyrinogen 
gave divinyl product with little of the intermediary monovi-
nyl species being detected. The isomeric 13-ethyl porphyrin-
ogen gave mostly the monovinyl product. Nevertheless, the 
observation that longer incubation times with the 13-ethyl 
analog resulted in some minor amount of divinyl product 
being generated is signiﬁ cant. When comparing all the di-
propionate substrates, the dibutyl analog was the least well 
HO2C
HO2CHO2C
HO2C
CO2H
CO2H
CO2H CO2H
CO2H
O2
O2
CH3
CH3
CH3 CH3
CH3
CH3
CH3
Coproporphyrinogen-II
Protoporphyrinogen-IX
Harderoporphyrinogen
CH3 CH3
CH3
CH3
CH3
A B
C D
NH
NH
HN
HN
NH
NH
HN
HN
NH
NH
HN
HN
Figure 1.  Overall reaction catalyzed by copro’gen 
oxidase of coproporphyrinogen-III to 
protoporphyrinogen-IX through the two 
sequential oxidative decarboxylations.
Figure 2.  Active Site Model of Copro’gen Oxidase [4].
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processed. The Vmax for the dibutyl was almost 30 fold low-
er than that of the dipropyl and 3–4 orders of magnitude 
worse than the largest Vmax value, 13-ethyl. Also, the Km val-
ue was 10–12 times larger than the best analog, indicating 
that the binding of this dibutyl analog is severely compro-
mised. With these bulky propyl and butyl groups present 
on both the C and D rings, it was predicted that the bind-
ing afﬁ nity would be affected. However, when comparing 
the Km values of the dipropyl and dibutyl analogs, the val-
ues were the same implying a similar poor ﬁ t into the active 
site. The two analogs differ in their Vmax values with the di-
propyl having a higher Vmax value. These data indicated that 
the extra methylene group on each of the C and D rings in 
the dibutyl slows down catalysis with no apparent difference 
in binding. When comparing the dipropyl and dibutyl to 
the kinetics obtained using diethyl (meso’gen-VI), the Vmax 
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For 17-Ethyl (R1=P; R2=Et), this is the only observed product.
For  13-Ethyl (R1=Et; R2=P), this is a minor product. The products
were analyzed as the coresponding porphyrin methyl esters.
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Figure 3.  Structure of Di- and Tri-propionate 
Porphyrinogen Analogs.
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for the diethyl porphyrinogen was about 3 orders of magni-
tude faster than that with the dipropyl and 4 orders faster 
than with the dibutyl analog. The Km values for the analogs 
also varied by a factor of 3–4 with diethyl having a Km value 
of 0.56 μM and the dipropyl and dibutyl analogs both hav-
ing values of 11 μM. It appears that the binding afﬁ nity as 
well as catalysis is more favorable with shorter alkyl substit-
uents present on both the C and D rings. This observation 
was further supported by the results for the dimethyl sub-
strate analog. The Km value for dimethyl was 0.11 μM and 
the maximum velocity was found to be about the same as 
that of the diethyl analog. Interestingly, at higher concen-
trations of dimethyl this analog appeared to show inhibito-
ry effects while the other analogs did not. With good bind-
ing afﬁ nity but moderate catalysis, the dimethyl analog at 
high concentrations may, in effect, occupy the active site 
for a longer time before it can undergo catalysis creating 
the apparent inhibitory effect.
The kinetic data presented here for the dipropionate ana-
logs indicate that the shorter the carbon chain substituent 
present on the C and D ring the better the kinetic constants. 
Comparisons of kinetic constants of the crude chicken red 
blood cell (CRBC) enzyme preparation to the recombinant 
human copro’gen oxidase show a similar inhibitory trend 
as the substituent carbon length on the C and D rings is in-
creased (Figure 10 and Table 2). However, the Vmax values 
for the crude CRBC enzyme [9] are about half of the values 
for the human recombinant copro’gen oxidase.
The tripropionate analogs were synthesized with an ethyl 
group on either the C or D ring at the 13 or 17 positions. The 
13-ethyl analog primarily underwent the ﬁ rst oxidative decar-
boxylation and a divinyl product was only formed to a minor 
extent. However, moving the ethyl group over to the 17-posi-
tion resulted in detection of only divinyl product. Since the 
monovinyl product is an obligatory intermediate, we interpret 
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these data to indicate that the ﬁ rst oxidative decarboxylation 
is slower than the second reaction which supports the work of 
Elder et al. [13]. Thus only the second (divinyl) product is de-
tectable under our experimental conditions using the 17-ethyl 
analog. When comparing the Km values of the tripropionates, 
17-ethyl had a Km value of 0.011 μM which was surprisingly 
lower than the value for the authentic substrate. In contrast, 
the 13-ethyl had a Km of 0.85 μM which is very similar to that 
using the authentic substrate. It is clear that replacement of 
the propionate by an ethyl group at the 17-position affects 
the binding afﬁ nity more positively than the ethyl group at 
the position 13. However, the maximum velocity using 13-eth-
yl was more than an order of magnitude faster than the Vmax 
using the 17-ethyl. It is not apparent why the Vmax should be 
so variable between these isomeric analogs.
As had been observed in incubations with the dimethyl por-
phyrinogen, the use of the 17-ethyl analog showed an appar-
ent inhibition of product formed as a function of substrate 
concentration. This inhibition was seen at lower concentra-
tions (between 1–2 μM) than with the dimethyl (3–6 μM). 
This difference in concentration dependence could be ex-
plained by the differences in the binding afﬁ nity between 
each substrate. The Km value for dimethyl was 0.11 μM which 
was 10-fold higher than the 0.011 μM value for the 17-ethyl 
analog. Since these Km values are for the formation of mo-
novinyl (using dimethyl) or divinyl product (using 17-eth-
yl), this may imply that the divinyl product is more able to 
affect interaction of enzyme with substrate.
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Figure 10.  Comparison of Vmax values for human recombinant 
copro’gen oxidase (z) and chicken red blood cell copro’gen 
oxidase ({) [9].
Substrate Product Vmax* Km (μM) kcat (min
–1) kcat/Km
Copro’gen-III**
Divinyl 3.3×10–3  0.70  3.3  4.7
Total 3.6×10–3  0.68  3.6  5.3
13-Ethyl Monovinyl 1.7×10–3  0.85  1.7  2.0
17-Ethyl Divinyl 1.0×10–4  0.011  0.10  9.1
diMethyl Monovinyl 5.0×10–4  0.11  0.050  0.45
diethyl Monovinyl 3.8×10-4  0.56  0.38  0.68
diPropyl Monovinyl 9.9×10–6  11.0 9.9×10–3 9.1×10–4
diButyl Monovinyl 3.6×10–7  11.0 3.6×10–4 3.4×10–5
Table 1. Kinetic constants for substrate analogs incubated with the human recombinant copro’gen oxidase.
* Vmax – nmol product/min/pmol Enzyme; ** Cooper et al., 2005 [14].
Vmax* Km (μM)
Substrate HCPO CRBC HCPO CRBC
13-Ethyl  2.6  0.21  0.85  2.0
17-Ethyl  0.048  0.055  0.011  0.88
diMethyl  0.33  0.14  0.11  1.0
diEthyl  0.24  0.095  0.56  0.99
diPropyl  0.0064  0.012  11.0  0.35
diButyl  0.00030  0.00011  11.0  0.10
Table 2.  Comparison of human recombinant copro’gen oxidase and chicken red blood cells kinetic constants (using same units of activity) for the di- 
and tripropionate analogs.
* Vmax – μM Product/min; CRBC – Chicken Red Blood Cell Hemolysates [9]; HCPO – Human Recombinant Copro’gen Oxidase.
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CONCLUSIONS
It is apparent from these studies that the substituents on the 
C and D rings of the porphyrin are necessary for not only 
proper binding but also efﬁ cient catalysis. As the substituent 
hydrocarbon length was increased, on both the C and D rings, 
the enzyme kinetics were hindered relative to the authentic 
substrate. However, the tripropionate substrate analogs re-
sulted in better binding afﬁ nity in the case of the 17-ethyl, 
and an increased rate of catalysis in the case of the 13-ethyl 
substitution. The formation of some divinyl product in the 
13-ethyl case was unexpected and suggests that binding to 
site X by a propionate moiety in the active site model is not 
an absolute requirement for catalysis. It was interesting to 
note that the largest kcat/Km value (catalytic efﬁ ciency) val-
ue was calculated using the 17-ethylporphyrinogen as sub-
strate. These data indicate that substituents on both the 13- 
and 17-ring positions of the substrate have important roles in 
binding and catalysis of substrate by the enzyme copro’gen 
oxidase. Thus the early model of the active site needs revi-
sion to account for these effects. As indicated in the work by 
Cooper et al. [14] and extended by this work, the effects of 
ring substituents on accumulation of porphyrin intermedi-
ates is substantial and will impact the severity of the clinical 
symptoms presented by porphyric patients.
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